Stephen Osborne, CEO, CSO and Founder

BIO | Dr. Stephen Osborne is the founder, CEO and Chief Scientific Officer of Pastel BioScience.

With over 20 years of working for biotechnology and diagnostic companies Stephen has a wealth of experience ranging from (i) highly technical expertise in molecular biology, recombinant protein expression and purification as well as IVD assay development [immunochemistry and MDx], (ii) high level project and people management as Manager of Italian R&D facility for DiaSorin S.p.A. a European diagnostics manufacturer (€1.7bn mkt cap.); 20 research scientists and €3 million annual R&D budget, (iii) experience in biotech company start-up and finance raising; and (iv) a good knowledge of the financial markets; 3 years as financial analyst for a London based stock broking company; final position held was as Associate Director & Head Analyst of Biotechnology & Healthcare Research, FSA Reg.

Stephen obtained a B.Sc. in Biotechnology from the University of London and a Ph.D in Biochemical Engineering from UCL. He has published in the areas of aqueous/organic two-phase biocatalytic systems, prokaryotic and eukaryotic recombinant protein expression for use in diagnostic assays and also novel IVD assay design.

  • T 0044 794 482 9778
  • E
Stephen Osborne vCard
Other Team Members

Pastel BioScience plans to recruit other team members including a number of scientist positions and that of CEO over the next 12 to 18 months. Please look at the Careers section for updated information on the current opportunities.

Web Analytics